ACI Archean Chemical Industries Q1 FY27 results (Apr–Jun 2026) and concall
Archean Chemical Industries Limited delivered strong Q1 FY27 results with significant revenue and EBITDA growth driven by record bromine volumes and Acume's first-time EBITDA positivity. However, profitability was tempered by elevated logistics costs and raw material price volatility, leading to a decline in industrial salt volumes and a correction in bromine spot prices in China. Strategic projects like SOP and SiCSem are progressing as planned.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q1 FY27: revenue up 13.3%, net profit down 21.2% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 238 | 243 | 322 | 279 | 221 −7% | 250 +3% | 292 −9% | 316 +13% |
| EBITDA | 76 | 84 | 90 | 83 | 65 −14% | 59 −30% | 54 −40% | 68 −18% |
| Net profit | 22 | 56 | 58 | 52 | 38 +73% | 34 −39% | 30 −48% | 41 −21% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.





